You are running your hands along your dog's side when your fingers land on something soft and squishy under the skin, something that wasn't there before, or perhaps something you've been half-noticing for a while without quite registering. Your first instinct might be alarm. But if your dog is a middle-aged or senior Labrador, Weimaraner, or Doberman, there is a genuinely good chance you've just found a lipoma — one of the most common, most benign, and most frequently misunderstood lumps in all of veterinary medicine.

Lipomas are fatty tumors. The vast majority are simple, slow-growing, non-cancerous masses that never threaten a dog's health and may never need treatment. They are so common in certain breeds that living with a lumpy dog becomes a part of daily life for many families. In a large UK study of dogs under primary veterinary care, lipomas were among the most frequently diagnosed disorders overall, and in high-risk breeds like the Weimaraner and Doberman, the lifetime prevalence approaches 7 to 8 percent.

But the story does not end there. A minority of fatty tumors behave very differently: infiltrative lipomas invade surrounding muscle and connective tissue, recur aggressively after removal, and require advanced treatment including radiation therapy. And the rare liposarcoma, the malignant counterpart to the lipoma, demands urgent, aggressive intervention. Knowing the difference between these types, and knowing when to act, is the purpose of this guide.

What Is a Lipoma?

A lipoma is a benign (non-cancerous) tumor arising from adipocytes — fat cells — within the body's connective tissue. In dogs, lipomas develop most commonly in the subcutaneous (under-skin) layer of connective tissue, where they form soft, moveable, well-defined masses. They are among the most common tumors diagnosed in dogs overall, and among the most common tumors diagnosed by cytology in primary veterinary practice.

The term "fatty tumor" is used colloquially by many veterinarians and dog owners and accurately describes the basic nature of a simple lipoma: an encapsulated collection of fat cells that is histologically normal, grows slowly, does not invade neighboring structures, and does not spread to other parts of the body.

The challenge — and the reason every lump still needs veterinary assessment — is that physical examination alone cannot reliably distinguish a simple benign lipoma from an infiltrative lipoma, a liposarcoma, a mast cell tumor, or several other conditions that can produce similarly soft, fatty-feeling masses under the skin.

The Spectrum: Three Very Different Diagnoses

Understanding lipomas requires clearly distinguishing between three related but meaningfully different conditions:

Simple (Classic) Lipoma

The common, benign fatty tumor. It sits in the subcutaneous tissue, is well-encapsulated, freely moveable under the skin, soft to the touch, and non-painful. It grows slowly — often over months to years — and does not invade surrounding muscle, bone, or nerves. It does not metastasize. The prognosis following complete surgical removal is excellent, with recurrence rare. Many simple lipomas never require removal at all.

Infiltrative Lipoma

An infiltrative lipoma is histologically similar to a simple lipoma — it is composed of well-differentiated, mature fat cells — but it behaves very differently. Instead of remaining encapsulated, it grows between and through muscle fibers, fascia, and connective tissue, spreading without forming clear margins. It does not have the clean "envelope" of a simple lipoma that makes surgical excision straightforward.

Infiltrative lipomas are considered benign because the fat cells themselves do not show histological criteria for malignancy, and metastasis has not been reported in dogs. But their behavior is locally aggressive: they are difficult to remove completely, they recur frequently after surgery, and they can cause significant morbidity by compressing nerves, restricting joint movement, and in some locations (axilla, thoracic inlet, spinal canal) causing lameness, weakness, or even neurological deficits.

They are clinically distinct from simple lipomas and represent a genuinely different management challenge.

Liposarcoma

Liposarcoma is the malignant tumor of fat cells — the cancer of this family. Unlike infiltrative lipomas, liposarcomas have histological criteria of malignancy: cellular atypia, high mitotic rates, abnormal cell architecture. They invade surrounding tissues aggressively and, importantly, have metastatic potential — though in dogs, distant metastasis appears to be less common than local invasion and recurrence. Liposarcomas require aggressive surgical excision and sometimes radiation therapy. They are rare compared to lipomas, but the consequences of treating one as if it were a simple lipoma — without adequate margins, without imaging, without specialist involvement — can be severe.

Clinical Rule of Thumb: Any fatty-feeling mass that is firm rather than soft, fixed to underlying tissue rather than freely moveable, or that has grown rapidly should be considered a potential infiltrative lipoma or liposarcoma until proven otherwise. Always pursue FNA cytology, and consider CT imaging before any surgical intervention.

How Common Are Lipomas? Epidemiology and Prevalence

Lipomas are among the most prevalent tumors diagnosed in dogs in primary veterinary practice:

• In a major UK VetCompass study of 384,284 dogs under primary veterinary care during 2013, the one-year prevalence of lipoma diagnosis was 1.94 percent — nearly 2 in every 100 dogs seen, annually, across all breeds and ages
• Lipomas were the second most commonly diagnosed tumor in insured UK dogs, with an incidence of 337 per 100,000 dogs per year
• In Danish cancer registry data, lipomas were the most common benign tumor, accounting for 24 percent of all benign tumor diagnoses
• In Golden Retrievers specifically, fatty tumors were the most commonly diagnosed tumor type by cytology

These figures represent dogs under active veterinary care. The true prevalence of lipomas in the general dog population — including those with lumps that are never evaluated — is likely considerably higher.

Risk Factors

Age

Age is the strongest risk factor for lipoma development. The VetCompass UK study found that dogs aged 9 to 12 years had 17.52 times the odds of lipoma diagnosis compared with dogs under 3 years of age. Lipomas are uncommon in young dogs and become progressively more common with each year of age. This strong age association led the study authors to propose that lipoma should be considered one of the accepted common diseases of aging in dogs.

Breed

Breed predisposition to lipoma is strong and well-documented, consistent with a genetic component to risk:

High-risk breeds:

• Weimaraner — highest prevalence in UK data: 7.84%
• Doberman Pinscher — 6.96%
• German Shorthaired Pointer — 5.23%
• English Springer Spaniel — 5.19%
• Labrador Retriever — 5.15%
• Miniature Schnauzer
• Cocker Spaniel
• Beagle
• Shetland Sheepdog
• Dachshund

Lower-risk breeds (identified in UK data as having significantly lower odds than crossbreeds): Yorkshire Terrier, Chihuahua, Staffordshire Bull Terrier, Jack Russell Terrier, Boxer, Shih Tzu, West Highland White Terrier, and Cavalier King Charles Spaniel. Notably, all low-risk breeds tend to be smaller in body size with less pronounced thoracic-abdominal body proportions compared to the high-risk group.

Body Weight / Obesity

Dogs weighing at or above the mean for their breed and sex had approximately twice the odds (OR = 1.97) of lipoma diagnosis in the VetCompass study. The relationship between increasing body weight and increasing lipoma risk was consistent across the population. This is analogous to human data, where lipoma risk is elevated in patients with obesity, hyperlipidemia, and diabetes mellitus. Maintaining a healthy body weight is the most actionable lifestyle-based risk reduction measure available to dog owners.

Sex and Reproductive Status

Female dogs are more commonly affected by lipomas than male dogs. Spayed and neutered dogs have higher reported rates of lipoma than intact dogs in some studies, though this relationship may reflect confounding from age and body weight rather than a direct hormonal effect.

Trauma

Anecdotally, some dogs have been reported to develop lipomas at sites of prior physical injury. The mechanism is not fully understood and the evidence base is limited.

Common Locations

Lipomas can develop anywhere fat is present in the body. The most common sites are:

• Chest wall and thorax (flanks) — most common overall
• Abdomen — both subcutaneous and, less commonly, intraabdominal
• Upper limbs and shoulder region
• Axilla (armpit) — clinically important because even small lipomas here can interfere with normal gait
• Groin / inguinal region
• Upper thighs and hips

Less common but clinically significant locations include:

• Intramuscular — lipomas embedded within muscle tissue rather than the subcutaneous layer; these may not be palpable from the surface and are often discovered incidentally on imaging
• Intraabdominal / retroperitoneal — can grow to enormous size within the abdominal cavity before causing symptoms
• Intraspinal / extradural — rare; lipomas in the spinal canal can cause progressive hind limb weakness and paralysis by compressing the spinal cord
• Intermuscular — lipomas between muscle groups, particularly in the shoulder and thigh regions; these tend to be firmer and less mobile than subcutaneous lipomas
• Cardiac / intrathoracic — very rare; requires imaging for detection

Recognizing a Lipoma: What Owners Typically Notice

Classic simple lipoma presentation:

• Soft, squishy mass under the skin — often described as feeling like a water balloon or a bag of putty
• Freely moveable — you can shift it around beneath the skin with gentle pressure
• Smooth surface, well-defined edges
• Non-painful — the dog does not react to gentle palpation
• Slow growth — often noticed first as a small "bump" that gradually increases over months
• Multiple lipomas are common — dogs rarely develop just one; many senior dogs accumulate numerous lipomas

Signs that should raise concern:

• Firm or hard consistency — unlike the typical soft, squishy feel
• Fixed to underlying tissue — cannot be moved freely under the skin
• Rapid growth — visible enlargement over days to a few weeks
• Pain on palpation — dog reacts or winces when the mass is touched
• Skin ulceration or discharge from the surface
• Lameness or gait change when a mass develops on a limb
• Weakness of the hind limbs (potential spinal involvement)
• Difficulty breathing (intrathoracic mass)
• Abdominal distension without obvious cause

Important Warning: Do not assume a mass is a lipoma simply because it feels soft and your dog has had lipomas before. Every new mass — even in a dog with a long history of confirmed benign lipomas — deserves fresh evaluation. Mast cell tumors, soft tissue sarcomas, and other malignancies can produce masses that feel very similar to lipomas on palpation.

Diagnosis

Fine Needle Aspirate (FNA) Cytology

FNA is the standard first-line diagnostic test for suspected lipomas. A small needle is inserted into the mass and cells are collected for microscopic examination. When a true lipoma is present, FNA yields clusters of normal-appearing adipocytes (fat cells) with abundant intracytoplasmic fat vacuoles — a distinctive and diagnostic cytological pattern.

FNA cytology for lipomas is minimally invasive, can be performed without sedation in most dogs, is low cost, and provides results within minutes to days. It is the appropriate initial step for most soft, moveable masses in the subcutaneous tissue.

Limitations of FNA:

• FNA samples a small number of cells from one area of the mass. In rare cases, other tumor types can be missed if the needle passes only through a fatty region of a mixed or complex tumor
• FNA cannot reliably distinguish simple lipomas from infiltrative lipomas — the fat cells look identical at the cytological level. Infiltrative lipoma diagnosis depends on the combination of cytology, clinical features (firmness, fixation), and imaging
• FNA cannot assess architecture or invasion — features that distinguish infiltrative lipoma from simple lipoma require histopathology and imaging
• A lipoma-like cytological result from a mass that is firm or fixed should prompt additional workup, not reassurance

Biopsy and Histopathology

Biopsy — surgical removal of tissue for microscopic examination — is required to definitively diagnose infiltrative lipoma or liposarcoma. Histopathology identifies cell type, architectural features, invasion of adjacent structures, mitotic index, and cytological atypia. For infiltrative lipomas, extensive histological sampling of the excised specimen is essential to demonstrate infiltration and to exclude liposarcoma, with which it can be confused.

When a mass is surgically excised as treatment (not just biopsy), the entire specimen should be submitted for histopathological evaluation. This is true even for masses that appear clinically benign — important information about margins, tissue type, and malignant features can only come from pathological examination of the excised tissue.

Imaging: Ultrasound

Ultrasound can assess subcutaneous masses and identify lipomas in the abdominal cavity or intramuscular locations that are not palpable from the surface. Simple lipomas typically appear homogeneous on ultrasound. However, as with FNA, ultrasound alone cannot reliably distinguish simple from infiltrative lipomas.

Imaging: CT (Computed Tomography)

CT is essential for:

1. Infiltrative lipoma assessment: CT characterizes the full three-dimensional extent of an infiltrative lipoma — how deeply it has invaded muscle, which fascial planes it crosses, whether it involves joints, nerves, or the spinal canal. This is critical for surgical planning and radiation therapy planning. Studies show infiltrative lipomas on CT typically appear as fat-attenuating masses with an irregular shape and linear hyperattenuating components extending into surrounding tissue — distinctly different from the smooth, well-defined appearance of simple lipomas
2. Liposarcoma assessment: CT features favoring liposarcoma over lipoma or infiltrative lipoma include heterogeneous attenuation with soft tissue components, contrast enhancement (liposarcomas enhance; simple lipomas typically do not), multinodular appearance, and lack of a clearly defined capsule with evidence of tissue infiltration. Regional lymphadenopathy and mineralization are additional features favoring liposarcoma
3. Deep or internal lipoma assessment: CT is the best modality for characterizing intraabdominal, retroperitoneal, or intraspinal fatty masses
4. Staging for liposarcoma: CT of the chest and abdomen to evaluate for regional lymph node involvement and distant metastasis

Treatment

Watch and Wait: When No Treatment Is Needed

For the vast majority of confirmed simple lipomas, no treatment is required. The standard approach is active monitoring — examining the mass at each wellness visit, tracking size, and intervening surgically only if specific indications arise.

Indications that monitoring is appropriate (surgery not immediately required):

• Small to moderate-sized mass with confirmed lipoma cytology
• Freely moveable, soft, non-painful
• Not interfering with gait, movement, or normal function
• Not in a location prone to trauma or ulceration
• Dog owner comfortable with monitoring

Monitoring protocol: Measure and document the mass at each veterinary visit. Many veterinarians use a simple sketch diagram showing the dog's body with lipoma locations and approximate sizes noted. Any change in character — firmness, reduced mobility, accelerated growth, pain — should trigger reassessment.

Practical Consideration: Owners often ask, "When should I have a lipoma removed while it's still small, rather than waiting?" There is logic to this question: removing a small lipoma involves a smaller incision, shorter surgery, faster recovery, and lower complication risk than removing a large mass. Your veterinarian may recommend proactive removal for lipomas in the axilla (armpit) or other locations where growth will impair function before a large size is reached, or for lipomas that have been growing steadily and are in a location where future access will be difficult. The risk of seroma formation (fluid accumulation in the cavity left by a large mass) is a genuine surgical complication of removing very large lipomas.

Surgical Excision of Simple Lipomas

For simple lipomas requiring treatment, complete surgical excision is curative. A simple lipoma has a natural capsule that allows the surgeon to dissect it away from surrounding tissue cleanly. When removal is complete, recurrence is rare. New lipomas may develop in other locations — particularly in predisposed breeds — but the removed mass does not regrow.

Surgical planning considerations:

• Location: Axillary lipomas can be deceptively invasive despite appearing simple — what seems like a well-defined mass on external palpation may have extensions into surrounding tissue. Surgical access and complete excision can be challenging in the axilla
• Size: Very large lipomas (softball-sized or larger) may benefit from pre-surgical CT to characterize extent, plan incision approach, and anticipate potential complications
• Concurrent health status: Older dogs with multiple lipomas and concurrent health conditions require careful anesthetic risk assessment
• Weight: Dogs that are significantly overweight may benefit from weight loss prior to surgery, as excess body fat can obscure tumor margins and complicate dissection

Treatment of Infiltrative Lipomas

Infiltrative lipomas present a fundamentally different treatment challenge from simple lipomas. Their lack of clear margins and their infiltration through muscle and connective tissue make complete surgical excision difficult or impossible in many cases. The recurrence rate after surgery alone is high — historically reported at 50 to 62.5 percent.

Surgical approach:

Wide surgical excision — removing the mass with as generous a margin of surrounding tissue as surgically achievable — provides the best chance of local control and is the first-line treatment. CT imaging before surgery is strongly recommended to map the full extent of invasion and guide surgical planning. Despite best efforts, complete excision is frequently not achieved. Multiple surgical procedures before definitive control are common.

Radiation therapy:

For infiltrative lipomas that cannot be completely excised, or where recurrence has occurred despite surgery, radiation therapy has emerged as an effective treatment with durable long-term outcomes.

Two recent multi-institutional retrospective studies (Feng et al., JAVMA 2023; Hauser et al., Veterinary and Comparative Oncology 2024) have provided the strongest evidence to date for radiation therapy in infiltrative lipomas. In the Feng 2023 study of 24 dogs treated with conventionally fractionated radiation therapy (45–51 Gray in 15–20 daily fractions), the estimated median overall survival after completing radiotherapy was approximately 4.8 years (1,760 days) — a remarkable outcome for a disease previously considered difficult to control. Dogs with complete radiotherapy had long-term local control, and some dogs remained disease-free for over 9 years.

Key findings from the radiation therapy literature:

• Conventionally fractionated radiation therapy (daily fractions over 3 to 4 weeks) is the most common protocol used
• Both gross (visible remaining tumor) and microscopic (post-surgical, margins incomplete) disease can be treated
• Acute radiation effects (skin reddening, moist desquamation) are expected and manageable; late effects can include fibrosis
• Location affects outcomes — limb and trunk lesions appear to respond well; head and neck lesions are also treatable
• Metastatic disease from infiltrative lipoma has not been reported, making local control the primary treatment goal

Radiation therapy for infiltrative lipoma requires referral to a veterinary radiation oncology center. The protocol involves daily treatment visits (usually under brief anesthesia) over several weeks. Planning requires CT simulation to precisely define the treatment volume.

Important Distinction: Infiltrative lipomas are not cancer — they do not metastasize. The goal of treatment is to prevent local recurrence and preserve function. Dogs with well-controlled infiltrative lipoma can live for years with excellent quality of life. The long survival times reported in radiation therapy studies reflect this reality.

Treatment of Liposarcoma

Liposarcoma is rare but requires aggressive management distinct from both simple and infiltrative lipomas.

Surgery: Wide surgical excision with generous margins is the primary treatment. Unlike simple lipomas, surgical margins of 2 to 3 cm are targeted where anatomically feasible, similar to soft tissue sarcoma margin guidelines. Complete excision significantly improves outcomes. If the mass is on a limb and complete excision with adequate margins is not possible while preserving function, amputation may be considered.

Radiation therapy: Adjuvant radiation therapy following surgery — or as primary treatment for incompletely excised masses — follows protocols similar to other soft tissue sarcomas. Evidence for liposarcoma specifically is limited by the rarity of the diagnosis.

Chemotherapy: The role of chemotherapy for canine liposarcoma is not well-established. Unlike HSA or osteosarcoma, there is no robust evidence base for adjuvant systemic chemotherapy, though it may be considered for confirmed metastatic disease or high-grade tumors. Doxorubicin-based protocols have been used in some cases.

Prognosis: Prognosis for liposarcoma depends on histological grade, completeness of excision, and presence of metastasis. Low-grade liposarcomas with complete excision can have prolonged disease-free intervals. High-grade liposarcomas carry a worse prognosis. CT imaging for staging (thorax and abdomen) is recommended for all liposarcoma patients.

Special Situations and Atypical Presentations

Axillary (Armpit) Lipomas

Lipomas in the axilla — the armpit region — deserve special mention because of their disproportionate functional impact. Even a relatively small axillary lipoma can interfere with normal forelimb motion, causing altered gait, reluctance to exercise, or lameness. The axilla is also a location where lipomas can appear well-defined on external palpation but actually have significant extensions into surrounding tissue that are not appreciated without imaging. Surgical access to the axilla is challenging, and complete excision can be difficult. Proactive removal of axillary lipomas at a moderate size, before they enlarge further, is generally recommended rather than watchful waiting.

Intramuscular and Intermuscular Lipomas

Lipomas that develop within or between muscle groups are not palpable in the same way as subcutaneous lipomas. They may present as a firm area of swelling, focal muscle atrophy, or unexplained lameness. They are typically firmer and less mobile than subcutaneous lipomas. CT or MRI is essential for characterizing these masses before any surgical intervention.

Intraabdominal and Retroperitoneal Lipomas

Very large intraabdominal lipomas — sometimes reaching several kilograms — can develop with minimal external signs until they create abdominal distension or compress abdominal organs. These are typically discovered on imaging (ultrasound or CT). CT characterization before surgery is essential to plan the operative approach, particularly given the risk of adjacent organ displacement.

Spinal / Extradural Lipomas

Lipomas arising in the extradural space of the spinal canal can compress the spinal cord, producing progressive neurological signs — hindlimb weakness, ataxia, paralysis, fecal or urinary incontinence. This is rare but represents one of the few clinical scenarios in which a "benign" lipoma is genuinely life-threatening. MRI is the imaging modality of choice. Surgical decompression (laminectomy) may restore neurological function if performed before permanent damage occurs.

"Lipoma-Like" Masses: The Critical Differentials

Several serious conditions can produce masses that feel similar to lipomas on palpation:

• Mast cell tumor — one of the most important differentials; can be soft and subcutaneous; extremely variable in appearance; always requires FNA at minimum
• Soft tissue sarcoma — may feel similar to a lipoma, particularly in early stages; requires histopathology for diagnosis
• Subcutaneous hemangiosarcoma — can be soft and subcutaneous; risk of hemorrhage
• Myxosarcoma / myxoma — gelatinous consistency similar to lipoma
• Vaccine-associated sarcoma — rare but aggressive; consider in any mass developing at a vaccination site

Every lump, every time. Even in a dog with a confirmed history of benign lipomas, every new lump should be assessed with FNA cytology. Do not assume a new mass is a lipoma because previous ones were.

Prognosis Summary

The Role of Weight Management

The evidence associating overweight body condition with lipoma development is consistent enough to make weight management a meaningful lifestyle recommendation — particularly for predisposed breeds. Dogs weighing above the mean for their breed and sex are approximately twice as likely to develop lipomas. Some veterinarians and owners also report that weight loss in overweight dogs with established lipomas can result in visible reduction in lipoma size, as the mass mobilizes fat alongside body reserves. While this anecdotal observation has not been rigorously studied, it is biologically plausible and represents an additional reason to maintain lean body condition throughout a dog's life.

Integrative and Nutritional Considerations

Weight and Diet

Maintaining a lean, healthy body weight through appropriate caloric intake and regular exercise is the most evidence-based nutritional recommendation for lipoma-prone dogs. High-quality protein-rich diets support lean body mass.

Supplements

Various supplements have been discussed anecdotally in the context of lipoma management, including vitamin C, vitamin B-12, chromium, and L-carnitine. The evidence base for these in dogs with lipomas is not scientifically established, and they should not replace veterinary assessment or treatment. Fish oil (omega-3 fatty acids EPA and DHA) has well-documented anti-inflammatory benefits in dogs and supports skin, joint, and metabolic health — and is generally appropriate as an adjunct to conventional care.

Frequently Asked Questions

My dog has a soft lump under the skin. My vet says it's "probably a lipoma." Do we still need to do a test?

Yes. "Probably a lipoma" is a clinical impression based on feel and presentation, not a diagnosis. FNA cytology is a quick, minimally invasive, low-cost test that provides actual diagnostic information — and more importantly, it can identify whether the mass might be a mast cell tumor, sarcoma, or another condition requiring immediate action. Every lump a dog develops deserves at least an FNA. The cost is low and the information is valuable.

My dog has eight lipomas and gets new ones every year. Do they all need to be removed?

No. Most lipomas in dogs with multiple masses simply need to be monitored. The decision to remove any individual lipoma is based on its location (is it interfering with movement or function?), rate of growth (is it growing rapidly?), size (is it getting so large that removal will be complicated?), and character (has it changed consistency or become less moveable?). Routine removal of all lipomas in a dog that develops them regularly is generally not medically indicated. Work with your veterinarian to identify which masses warrant active monitoring and which, if any, should be removed.

How do I know if a lipoma needs to be removed before it gets too big?

Good rule of thumb: lipomas in the axilla (armpit), near joints, or anywhere they are already causing gait changes or discomfort should be removed sooner rather than later. Lipomas on the chest wall or flank that are soft, freely moveable, and not causing any functional problem can often be monitored indefinitely. A lipoma that is growing noticeably from visit to visit, or that has changed in character (firmer, less moveable), should be reevaluated and likely removed. Your veterinarian can advise on proactive vs. watchful management based on specific location and trajectory.

My dog's lipoma has grown a lot. Now it won't move as freely. What does that mean?

Reduced mobility — a mass that was previously freely moveable and now feels more fixed to underlying tissue — is a reason for urgent veterinary reassessment. This change in character raises the possibility that what appeared to be a simple lipoma may actually be an infiltrative lipoma or a different type of tumor entirely. CT imaging and biopsy may be indicated before proceeding with any surgical approach.

What is an infiltrative lipoma and how is it treated differently?

An infiltrative lipoma is a type of lipoma that grows into surrounding muscle and connective tissue instead of remaining encapsulated. It cannot be shelled out like a simple lipoma — it has no clear edges. Surgery is the first-line treatment, but complete removal is often not possible, and recurrence is common. For recurrent or incompletely excised infiltrative lipomas, radiation therapy has produced excellent long-term outcomes — a median survival after radiation of approximately 4.8 years in one 2023 multi-institutional study. CT imaging before surgery is essential to understand the full extent of the mass and plan treatment. Importantly, infiltrative lipomas do not spread to other organs — the treatment goal is local control and preservation of function.

Could this lump be cancer? What is liposarcoma?

Liposarcoma is the malignant version of a fatty tumor — true cancer of the fat cells. It is rare compared to benign lipomas. On physical examination, liposarcomas may be softer or firmer than simple lipomas, and they often feel fixed to underlying tissue rather than freely moveable. FNA cytology showing fat cells but in a firm, fixed mass should not be assumed to be a simple benign lipoma — imaging and biopsy are needed. Liposarcomas are treated with wide surgical excision and sometimes radiation. They have metastatic potential, though in dogs this appears to be less common than in humans. A liposarcoma missed because it was assumed to be benign — and treated with marginal or no surgery — can progress significantly before the correct diagnosis is made. This is why every lump needs proper evaluation, even in a dog that has had many benign lipomas.

Can lipomas be prevented?

Not entirely, particularly in breeds with strong genetic predisposition. However, maintaining a lean body weight throughout your dog's life is the most evidence-based modifiable risk factor — dogs at or above their breed/sex mean weight have approximately twice the odds of developing lipomas compared to leaner dogs. Regular exercise, a high-quality diet in appropriate portions, and annual wellness examinations (twice yearly for senior dogs) will not prevent all lipomas but support overall health and ensure early detection.

My dog's lipoma seems to be compressing nearby tissue. Could it cause pain?

Simple lipomas are typically non-painful. However, very large lipomas can cause discomfort simply by their mechanical presence — by pressing on nerves, restricting joint movement, or making it difficult for the dog to lie comfortably. Axillary lipomas can interfere with gait. Lipomas near the spine can compress spinal cord structures and cause neurological pain or weakness. If your dog appears uncomfortable, guards the area, or has changed its gait or posture, the lipoma's location and size need to be reassessed.

References

1. O'Neill DG, Corah CH, Church DB, Brodbelt DC, Rutherford L. Lipoma in dogs under primary veterinary care in the UK: prevalence and breed associations. Canine Genetics and Epidemiology, 5:9, 2018. https://pmc.ncbi.nlm.nih.gov/articles/PMC6161450/
2. Feng Y, Kent MS, Théon AP, Hansen KS. Conventionally fractionated radiation therapy is associated with long-term survival in dogs with infiltrative lipomas. Journal of the American Veterinary Medical Association, 261(11):1–8, 2023. https://avmajournals.avma.org/view/journals/javma/261/11/javma.23.05.0288.xml
3. Hauser A, Thorsen L, Boss MK, Martin TW. A retrospective study evaluating the outcomes of conventionally fractionated radiation therapy as a treatment for infiltrative lipomas in twenty-one dogs. Veterinary and Comparative Oncology, 22(4):523–530, 2024. https://pubmed.ncbi.nlm.nih.gov/39288821/
4. Multi-institutional retrospective study of radiation therapy for infiltrative lipoma: outcome and prognostic factors in 29 dogs. PMC, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12378080/
5. Fuerst JA, Reichle JK, Szabo D, et al. Computed tomographic findings in 24 dogs with liposarcoma. Veterinary Radiology and Ultrasound, 58(1):23–28, 2017. https://pubmed.ncbi.nlm.nih.gov/27753170/
6. McEntee MC, Thrall DE. Computed tomographic imaging of infiltrative lipoma in 22 dogs. Veterinary Radiology and Ultrasound, 42(3):221–225, 2001. https://pubmed.ncbi.nlm.nih.gov/11428487/
7. McChesney AE, Stephens LC, Lebel J, et al. Infiltrative lipoma in dogs. Veterinary Pathology, 17(3):316–322, 1980. https://journals.sagepub.com/doi/10.1177/030098588001700305
8. Bergman PJ, Withrow SJ, Straw RC, Powers BE. Infiltrative lipoma in dogs: 16 cases (1981–1992). Journal of the American Veterinary Medical Association, 205(2):322–324, 1994. https://pubmed.ncbi.nlm.nih.gov/7928622/
9. McEntee MC, Page RL, Mauldin GN, et al. Results of irradiation of infiltrative lipoma in 13 dogs. Veterinary Radiology and Ultrasound, 41(6):554–556, 2000. https://pubmed.ncbi.nlm.nih.gov/11128845/
10. Spoldi E, Schwarz T, Sabattini S, Vignoli M, Cancedda S, Rossi F. Comparisons among computed tomographic features of adipose masses in dogs and cats. Veterinary Radiology and Ultrasound, 58(1):29–37, 2017. https://pubmed.ncbi.nlm.nih.gov/27762445/
11. Avallone G, Roccabianca P, Crippa L, et al. Histological classification and immunohistochemical evaluation of MDM2 and CDK4 expression in canine liposarcoma. Veterinary Pathology, 53(4):773–780, 2016. https://pubmed.ncbi.nlm.nih.gov/26682979/
12. Lipomas in Dogs. Cornell Richard P. Riney Canine Health Center, 2024. https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-information/lipomas-dogs
13. Withrow SJ, Vail DM, Page RL (Eds.). Withrow & MacEwen's Small Animal Clinical Oncology, 5th ed. Elsevier Saunders, 2013.
14. Villalobos AE. Lipoma and liposarcoma. In: Merck Veterinary Manual. https://www.merckvetmanual.com
15. O'Neill DG. Lipoma in dogs: how common are they and what breeds are affected? Veterinary Ireland Journal, 2019. https://www.veterinaryirelandjournal.com/small-animal/79-lipoma-in-dogs-how-common-are-they-and-what-breeds-are-affected

---

This article is intended for educational purposes only and does not constitute veterinary medical advice. Always consult a licensed veterinarian or board-certified veterinary oncologist for guidance specific to your dog's health needs.